XELJANZ XR 22 mg/1

XELJANZ XR 22 mg is an extended-release tablet containing tofacitinib, used for managing specific inflammatory conditions. This medication is designed for oral administration and is available in a 30-tablet bottle.

XELJANZ XR 22 mg is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib, the active ingredient, works by modulating the immune response to reduce inflammation and alleviate symptoms. Patients often wonder, 'What is XELJANZ XR used for?' This medication is typically prescribed when other treatments have not been effective or are not suitable.

Common effects of XELJANZ XR 22 mg may include upper respiratory tract infections, headache, and nausea. Some users might experience increased blood pressure or changes in cholesterol levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

XELJANZ XR 22 mg should be handled with care, especially for individuals with a history of infections, liver problems, or blood disorders. Regular blood tests may be recommended to monitor for potential side effects. Always follow the guidance of a healthcare professional regarding the use of this medication.

XELJANZ XR 22 mg may interact with certain medications, including those that affect the immune system or blood clotting. It's advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.